Our Science – McVicar Website
Daniel W. McVicar, Ph.D.
Selected Publications |
 |
| 1)
O'Connor GM, Basatena NS, Olavarria V, Macnamara A, Vine A, Ying Q, Hisada M, Galvão-Castro B, Asquith B, McVicar DW. In Contrast to HIV, KIR3DS1 Does Not Influence Outcome In HTLV-1 Retroviral Infection. Hum. Immunol. 73: 783-7, 2012. [Journal] |
|
| 2)
Derive M, Bouazza Y, Sennoun N, Marchionni S, Quigley L, Washington V, Massin F, Max JP, Ford J, Alauzet C, Levy B, McVicar DW, Gibot S. Soluble Trem-like Transcript-1 Regulates Leukocyte Activation and Controls Microbial Sepsis. J. Immunol. 188: 5585-92, 2012. [Journal] |
|
| 3)
O'Connor GM, Yamada E, Rampersaud A, Thomas R, Carrington M, McVicar DW. Analysis of Binding of KIR3DS1*014 to HLA Suggests Distinct Evolutionary History of KIR3DS1. J. Immunol. 187: 2162-71, 2011. [Journal] |
|
| 4)
Fadda L, O'Connor GM, Kumar S, Piechocka-Trocha A, Gardiner CM, Carrington M, McVicar DW, Altfeld M. Common HIV-1 Peptide Variants Mediate Differential Binding of KIR3DL1 to HLA-Bw4 Molecules. J. Virol. 85: 5970-4, 2011. [Journal] |
|
| 5)
Vivian JP, Duncan RC, Berry R, O'Connor GM, Reid HH, Beddoe T, Gras S, Saunders PM, Olshina MA, Widjaja JM, Harpur CM, Lin J, Maloveste SM, Price DA, Lafont BA, McVicar DW, Clements CS, Brooks AG, Rossjohn J. Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature. 479: 401-5, 2011. [Journal] |
|
| 6)
Orr SJ, Roessler S, Quigley L, Chan T, Ford JW, O'Connor GM, McVicar DW. Implications for gene therapy-limiting expression of IL-2Rgammac delineate differences in signaling thresholds required for lymphocyte development and maintenance. J. Immunol. 185: 1393-403, 2010. [Journal] |
|
| 7)
Orr SJ, McVicar DW. LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes?. J. Leukoc. Biol. 89: 11-9, 2010. [Journal] |
|
| 8)
Whittaker GC, Orr SJ, Quigley L, Hughes L, Francischetti IM, Zhang W, McVicar DW. The linker for activation of B cells (LAB)/non-T cell activation linker (NTAL) regulates triggering receptor expressed on myeloid cells (TREM)-2 signaling and macrophage inflammatory responses independently of the linker for activation of T cells. J. Biol. Chem. 285: 2976-85, 2010. [Journal] |
|
| 9)
Smrz D, Iwaki S, McVicar DW, Metcalfe DD, Gilfillan AM. TLR-mediated signaling pathways circumvent the requirement for DAP12 in mast cells for the induction of inflammatory mediator release. Eur. J. Immunol. 40: 3557-69, 2010. [Journal] |
|
| 10)
Ranatunga D, Hedrich CM, Wang F, McVicar DW, Nowak N, Joshi T, Feigenbaum L, Grant LR, Stäger S, Bream JH. A human IL10 BAC transgene reveals tissue-specific control of IL-10 expression and alters disease outcome. Proc. Natl. Acad. Sci. U.S.A. 106: 17123-8, 2009. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 4/19/2013.
